Oncology Intelligence Digest August 28, 2026 The FDA approved daraxonrasib (Rasonque) from Revolution Medicines on August 27, 2026,…
Oncology Intelligence Membership Required
You must be a Oncology Intelligence member to access this content.
Already a member? Log in here